2015
DOI: 10.1055/s-0035-1546271
|View full text |Cite
|
Sign up to set email alerts
|

Psychosocial Information Requirements for Multimorbid Breast Cancer Patients in Breast Centres in North Rhine Westphalia

Abstract: * Aus Gründen der besseren Lesbarkeit verwenden wir zumeist nur den Begriff "Brustkrebspatientinnen". Damit sind auch die männlichen Patienten gemeint, die an der Befragung teilgenommen haben. Ist umgekehrt von "Patienten" die Rede, so sind auch immer die Patientinnen eingeschlossen.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…To what extent these structures are adequate from the patients’ perspective has to be subject to further research. There are indications that the support needs of specific groups of patients with breast cancer, for example, patients with an immigration background, 12 patients with comorbidities, 13 patients receiving neoadjuvant chemotherapy or showing passive-resigning coping skills, 14 patients who are offered individualised treatment approaches based on molecular genetic methods, 15 male patients with breast cancer, or patients’ partners or caregivers, 16 17 have not yet been addressed adequately. Should subsequent studies reveal that disease-specific, treatment-related or target group-specific needs are not fully met, it will be necessary to examine the institutional determinants in order to derive specific measures for the underserved patient groups.…”
Section: Discussionmentioning
confidence: 99%
“…To what extent these structures are adequate from the patients’ perspective has to be subject to further research. There are indications that the support needs of specific groups of patients with breast cancer, for example, patients with an immigration background, 12 patients with comorbidities, 13 patients receiving neoadjuvant chemotherapy or showing passive-resigning coping skills, 14 patients who are offered individualised treatment approaches based on molecular genetic methods, 15 male patients with breast cancer, or patients’ partners or caregivers, 16 17 have not yet been addressed adequately. Should subsequent studies reveal that disease-specific, treatment-related or target group-specific needs are not fully met, it will be necessary to examine the institutional determinants in order to derive specific measures for the underserved patient groups.…”
Section: Discussionmentioning
confidence: 99%